---
title: "Metabolic heterogeneity in obesity: insulin sensitivity, organ differences and weight-loss respons"
id: "nature-0-metabolic-heterogeneity-of-obesity"
canonical_url: "https://medichelpline.com/clinical-feed/nature-0-metabolic-heterogeneity-of-obesity"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "Nature Medicine"
source_url: "https://www.nature.com/articles/s41591-026-04718-7"
published_at: "2026-10-27T11:22:10.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Metabolic heterogeneity in obesity: insulin sensitivity, organ differences and weight-loss respons
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-0-metabolic-heterogeneity-of-obesity
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** Nature Medicine
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41591-026-04718-7)
- **Published At:** 2026-10-27T11:22:10.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The article is a Review that frames multi-organ-system **insulin resistance** as the main driver of obesity-related metabolic disease while emphasising wide interindividual variability in metabolic status among people with obesity. - Some individuals with obesity maintain normal insulin sensitivity alongside normal fasting glucose, oral glucose tolerance, lipid profiles and intrahepatic triglyceride content; investigators refer to this group as **metabolically healthy obesity**. - The Review compares cellular, organ-system and systemic differences between metabolically healthy and metabolically unhealthy phenotypes, noting differences in adipose function, lipid handling and likely cross-talk between tissues. - Authors reported heterogeneity in clinical outcomes and in the metabolic effects of weight reduction; the study team observed that therapeutic responses to weight loss are not uniform across metabolically divergent groups. - The Review summarises proposed mechanistic models linking adipose tissue dysfunction to multi-organ **insulin resistance**, and it includes schematic figures of heterogeneity in insulin sensitivity, estimated prevalence of metabolic phenotypes, 24-h metabolic profiles, and proposed adipose-driven models. - The authors discussed implications for disease risks such as atherogenic dyslipidemia, **metabolic dysfunction-associated steatotic liver disease**, and **type 2 diabetes**, without providing new trial-level data in this Review article. - The source did not report primary trial numbers, specific intervention protocols, numeric prevalence ranges in the text preview, nor new experimental datasets; detailed methods and quantitative results are available only in the full Review text behind subscription access. - The Review references prior epidemiology, mechanistic and clinical management literature, and cites landmark and recent reviews and statements relevant to metabolic syndrome, obesity epidemiology, and long-term risk assessment.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41591-026-04718-7#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Medicine](https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg) ](https://www.nature.com/nm) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-026-04718-7) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/nm/research-articles) * [ Reviews & Analysis ](https://www.nature.com/nm/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/nm/news-and-comment) * [ Podcasts ](https://www.nature.com/nm/podcast) * [ Current issue ](https://www.nature.com/nm/current-issue) * [ Collections ](https://www.nature.com/nm/collections) * [Follow us on Facebook ](https://www.facebook.com/Nature-Medicine-193691346949/) * [Follow us on X ](https://twitter.com/naturemedicine) * [ Subscribe ](https://www.nature.com/nm/subscribe) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/nm/aims) * [ Journal Information ](https://www.nature.com/nm/journal-information) * [ Editors ](https://www.nature.com/nm/editors) * [ Journal Metrics ](https://www.nature.com/nm/journal-impact) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/nm/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/nm/reviews-cross-journal-editorial-team) * [ Statistical Advisory Panel ](https://www.nature.com/nm/statistics-advisory-panel) * [ Our publishing models ](https://www.nature.com/nm/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/nm/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/nm/editorial-policies) * [ Content Types ](https://www.nature.com/nm/content) * [ Web Feeds ](https://www.nature.com/nm/web-feeds) * [ Contact ](https://www.nature.com/nm/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/nm/submission-guidelines) * [ For Reviewers ](https://www.nature.com/nm/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/nm/open-access-funding) * [Submit manuscript ](https://mts-nmed.nature.com/cgi-bin/main.plex) * [ Subscribe ](https://www.nature.com/nm/subscribe) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41591) * [ RSS feed ](https://www.nature.com/nm.rss) 1. [nature](https://www.nature.com/) 2. [nature medicine](https://www.nature.com/nm) 3. [review articles](https://www.nature.com/nm/articles?type=review-article) 4. article * Review Article * Published: 27 October 2026 # Metabolic heterogeneity of obesity * [Gordon I. Smith](https://www.nature.com/articles/s41591-026-04718-7#auth-Gordon_I_-Smith-Aff1) [ORCID: orcid.org/0000-0003-0063-046X](https://orcid.org/0000-0003-0063-046X)[1](https://www.nature.com/articles/s41591-026-04718-7#Aff1), * [Max C. Petersen](https://www.nature.com/articles/s41591-026-04718-7#auth-Max_C_-Petersen-Aff1-Aff2)[1](https://www.nature.com/articles/s41591-026-04718-7#Aff1),[2](https://www.nature.com/articles/s41591-026-04718-7#Aff2), * [Sean M. Hartig](https://www.nature.com/articles/s41591-026-04718-7#auth-Sean_M_-Hartig-Aff3) [ORCID: orcid.org/0000-0002-2695-2072](https://orcid.org/0000-0002-2695-2072)[3](https://www.nature.com/articles/s41591-026-04718-7#Aff3) & * … * [Samuel Klein](https://www.nature.com/articles/s41591-026-04718-7#auth-Samuel-Klein-Aff1) [ORCID: orcid.org/0000-0001-7127-1156](https://orcid.org/0000-0001-7127-1156)[1](https://www.nature.com/articles/s41591-026-04718-7#Aff1) Show authors [_Nature Medicine_](https://www.nature.com/nm) (2026) [Cite this article](https://www.nature.com/articles/s41591-026-04718-7#citeas) Save article [ View saved research ](https://www.nature.com/saved-research) ## Abstract Multi-organ-system insulin resistance is the key pathogenic driver of obesity-related metabolic complications and diseases, such as atherogenic dyslipidemia, metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. However, there is considerable heterogeneity in insulin sensitivity among people with obesity. Some are considered to have metabolically healthy obesity, with normal insulin sensitivity in conjunction with normal fasting blood glucose, oral glucose tolerance, plasma lipid profile and intrahepatic triglyceride content. In this Review, we discuss metabolic differences at the cellular, organ-system and systemic levels between people with metabolically healthy and metabolically unhealthy obesity; we also discuss heterogeneity in the therapeutic effects of weight reduction. A better understanding of the differences between metabolically divergent groups and the physiological responses to weight loss can help identify the factors responsible for the link between excess adiposity and metabolic dysfunction and disease. This is a preview of subscription content, [access via your institution](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04718-7) ## Access options [ Access through your institution ](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04718-7) Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27.99 € / 30 days cancel any time [Learn more](https://shop.nature.com/products/plus/?region=ROW) Subscribe to this journal Receive 12 print issues and online access 251.40 € per year only 20.95 € per issue [Learn more](https://www.nature.com/nm/subscribe) Buy this article * Purchase on SpringerLink * Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout ### Additional access options: * [Log in](https://idp.nature.com/auth/personal/springernature?client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-026-04718-7) * [Learn about institutional subscriptions](https://www.springernature.com/gp/librarians/licensing/license-options) * [Read our FAQs](https://support.nature.com/en/support/home) * [Contact customer support](https://www.springernature.com/gp/contact) **Fig. 1: Heterogeneity in insulin sensitivity in people without diabetes.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04718-7/MediaObjects/41591_2026_4718_Fig1_HTML.png) **Fig. 2: Estimated percentage of people with obesity who are metabolically healthy and metabolically unhealthy.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04718-7/MediaObjects/41591_2026_4718_Fig2_HTML.png) **Fig. 3: 24-h metabolic profiles in people with metabolically healthy and metabolically unhealthy obesity.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04718-7/MediaObjects/41591_2026_4718_Fig3_HTML.png) **Fig. 4: Models proposed to explain adipose tissue-induced multi-organ insulin resistance.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-026-04718-7/MediaObjects/41591_2026_4718_Fig4_HTML.png) ### Explore related subjects Discover the latest articles and news in related subjects. * [Endocrinology](https://www.nature.com/subjects/endocrinology) * [Obesity](https://www.nature.com/subjects/obesity) * [Adipose Tissue Metabolism and Cardiovascular Health Outcomes](https://www.nature.com/subjects/adipose-tissue-metabolism-and-cardiovascular-health-outcomes) ## References 1. Klein, S., Wadden, T. & Sugerman, H. J. AGA technical review on obesity. _Gastroenterology_ **123** , 882–932 (2002). [Article](https://doi.org/10.1053%2Fgast.2002.35514) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12198715) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=AGA%20technical%20review%20on%20obesity&journal=Gastroenterology&doi=10.1053%2Fgast.2002.35514&volume=123&pages=882-932&publication_year=2002&author=Klein%2CS&author=Wadden%2CT&author=Sugerman%2CHJ) 2. Kciuk, M. et al. Alzheimer’s disease as type 3 diabetes: understanding the link and implications. _Int. J. Mol. Sci._ **25** , 11955 (2024). [Article](https://doi.org/10.3390%2Fijms252211955) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXis1GqurzL) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=39596023) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11593477) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Alzheimer%E2%80%99s%20disease%20as%20type%203%20diabetes%3A%20understanding%20the%20link%20and%20implications&journal=Int.%20J.%20Mol.%20Sci.&doi=10.3390%2Fijms252211955&volume=25&publication_year=2024&author=Kciuk%2CM) 3. Karra, P. et al. Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome. _Obesity_ **30** , 1323–1334 (2022). [Article](https://doi.org/10.1002%2Foby.23444) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XitF2js7jM) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35785479) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302704) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Metabolic%20dysfunction%20and%20obesity-related%20cancer%3A%20beyond%20obesity%20and%20metabolic%20syndrome&journal=Obesity&doi=10.1002%2Foby.23444&volume=30&pages=1323-1334&publication_year=2022&author=Karra%2CP) 4. Ndumele, C. E. et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement From the American Heart Association. _Circulation_ **148** , 1636–1664 (2023). [Article](https://doi.org/10.1161%2FCIR.0000000000001186) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37807920) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=A%20synopsis%20of%20the%20evidence%20for%20the%20science%20and%20clinical%20management%20of%20cardiovascular-kidney-metabolic%20%28CKM%29%20syndrome%3A%20a%20scientific%20statement%20From%20the%20American%20Heart%20Association&journal=Circulation&doi=10.1161%2FCIR.0000000000001186&volume=148&pages=1636-1664&publication_year=2023&author=Ndumele%2CCE) 5. Schulze, M. B. & Stefan, N. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications. _Nat. Rev. Endocrinol._ **20** , 633–646 (2024). [Article](https://doi.org/10.1038%2Fs41574-024-01008-5) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=38937638) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Metabolically%20healthy%20obesity%3A%20from%20epidemiology%20and%20mechanisms%20to%20clinical%20implications&journal=Nat.%20Rev.%20Endocrinol.&doi=10.1038%2Fs41574-024-01008-5&volume=20&pages=633-646&publication_year=2024&author=Schulze%2CMB&author=Stefan%2CN) 6. Smith, G. I., Mittendorfer, B. & Klein, S. Metabolically healthy obesity: facts and fantasies. _J. Clin. Invest._ **129** , 3978–3989 (2019). [Article](https://doi.org/10.1172%2FJCI129186) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31524630) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763224) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Metabolically%20healthy%20obesity%3A%20facts%20and%20fantasies&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI129186&volume=129&pages=3978-3989&publication_year=2019&author=Smith%2CGI&author=Mittendorfer%2CB&author=Klein%2CS) 7. National Cholesterol Education Program Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. _Circulation_ **106** , 3143–3421 (2002). [Article](https://doi.org/10.1161%2Fcirc.106.25.3143) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Third%20Report%20of%20the%20National%20Cholesterol%20Education%20Program%20%28NCEP%29%20Expert%20Panel%20on%20Detection%2C%20Evaluation%2C%20and%20Treatment%20of%20High%20Blood%20Cholesterol%20in%20Adults%20%28Adult%20Treatment%20Panel%20III%29%20final%20report&journal=Circulation&doi=10.1161%2Fcirc.106.25.3143&volume=106&pages=3143-3421&publication_year=2002) 8. Grundy, S. M. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. _Circulation_ **112** , 2735–2752 (2005). [Article](https://doi.org/10.1161%2FCIRCULATIONAHA.105.169404) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16157765) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Diagnosis%20and%20management%20of%20the%20metabolic%20syndrome%3A%20an%20American%20Heart%20Association%2FNational%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20Scientific%20Statement&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA.105.169404&volume=112&pages=2735-2752&publication_year=2005&author=Grundy%2CSM) 9. Kuk, J. L. & Ardern, C. I. Are metabolically normal but obese individuals at lower risk for all-cause mortality? _Diabetes Care_ **32** , 2297–2299 (2009). [Article](https://doi.org/10.2337%2Fdc09-0574) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19729521) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782994) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Are%20metabolically%20normal%20but%20obese%20individuals%20at%20lower%20risk%20for%20all-cause%20mortality%3F&journal=Diabetes%20Care&doi=10.2337%2Fdc09-0574&volume=32&pages=2297-2299&publication_year=2009&author=Kuk%2CJL&author=Ardern%2CCI) 10. Calori, G. et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. _Diabetes Care_ **34** , 210–215 (2011). [Article](https://doi.org/10.2337%2Fdc10-0665) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20937689) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Prevalence%2C%20metabolic%20features%2C%20and%20prognosis%20of%20metabolically%20healthy%20obese%20Italian%20individuals%3A%20the%20Cremona%20Study&journal=Diabetes%20Care&doi=10.2337%2Fdc10-0665&volume=34&pages=210-215&publication_year=2011&author=Calori%2CG) 11. Straznicky, N. E. et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. _Am. J. Clin. Nutr._ **89** , 27–36 (2009). [Article](https://doi.org/10.3945%2Fajcn.2008.26299) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXnsFKhtw%3D%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19056585) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Blunted%20sympathetic%20neural%20response%20to%20oral%20glucose%20in%20obese%20subjects%20with%20the%20insulin-resistant%20metabolic%20syndrome&journal=Am.%20J.%20Clin.%20Nutr.&doi=10.3945%2Fajcn.2008.26299&volume=89&pages=27-36&publication_year=2009&author=Straznicky%2CNE) 12. Brochu, M. et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? _J. Clin. Endocrinol. Metab._ **86** , 1020–1025 (2001). [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXitFWnsL8%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11238480) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=What%20are%20the%20physical%20characteristics%20associated%20with%20a%20normal%20metabolic%20profile%20despite%20a%20high%20level%20of%20obesity%20in%20postmenopausal%20women%3F&journal=J.%20Clin.%20Endocrinol.%20Metab.&volume=86&pages=1020-1025&publication_year=2001&author=Brochu%2CM) 13. Abbasi, F. et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. _Diabetes_ **53** , 585–590 (2004). [Article](https://doi.org/10.2337%2Fdiabetes.53.3.585) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXhvFelurg%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14988241) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Discrimination%20between%20obesity%20and%20insulin%20resistance%20in%20the%20relationship%20with%20adiponectin&journal=Diabetes&doi=10.2337%2Fdiabetes.53.3.585&volume=53&pages=585-590&publication_year=2004&author=Abbasi%2CF) 14. Tajik, S., Mirzababaei, A., Ghaedi, E., Kord-Varkaneh, H. & Mirzaei, K. Risk of type 2 diabetes in metabolically healthy people in different categories of body mass index: an updated network meta-analysis of prospective cohort studies. _J. Cardiovasc. Thorac. Res._ **11** , 254–263 (2019). [Article](https://doi.org/10.15171%2Fjcvtr.2019.43) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31824606) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891044) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Risk%20of%20type%202%20diabetes%20in%20metabolically%20healthy%20people%20in%20different%20categories%20of%20body%20mass%20index%3A%20an%20updated%20network
## Related Clinical Research

- [Later bedtimes and late eating tied to higher metabolic syndrome risk](https://medichelpline.com/clinical-feed/medical-news-today-0-eating-and-sleeping-later-associated-with-increased-health-risks.md)
- [Higher moderate-to-vigorous physical activity linked to lower type 2 diabetes risk](https://medichelpline.com/clinical-feed/medical-news-today-0-more-moderate-to-vigorous-physical-activity-could-reduce-type-2-diabetes-risk.md)
- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)
- [Genomic SEM identifies shared genetic architecture and candidate genes for insulin resistance–rela](https://medichelpline.com/clinical-feed/plos-one-18-integrative-genomic-sem-analysis-of-shared-genetic-architecture-and-candidate.md)
- [Preconception, Gestational, and Postpartum Care for Type 2 Diabetes](https://medichelpline.com/clinical-feed/endocrine-news-0-preconception-gestational-and-postpartum-care.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.